PE000147
Jump to navigation
Jump to search
| Name | K.VGQLQLSHN[H5N4S2]LSLVILVPQNLK.H |
|---|---|
| Sequence | VGQLQLSHNLSLVILVPQNLK |
| Glycans(s) | H5N4S2 (N9) |
| Mod(s) | |
| Molecular Weight | 4535.141 |
| Norm. RT | 115.122 |
| Protein | SERPING1 (P05155) |
Samples
DDA Transition Groups
| Exp. R.T. | Peak R.T. | Norm. R.T. | Prec. m/z | Prec. z | Inst. | Sample | Transitions | |
|---|---|---|---|---|---|---|---|---|
| TG001291 | 58.177 | 58.181 | 114.457 | 1,130.290 | 4 | Orbitrap | Human Serum | 11 |
| TG000752 | 57.795 | 57.690 | 115.528 | 1,130.290 | 4 | Orbitrap | Human Serum | 7 |
| TG000955 | 58.053 | 58.181 | 115.074 | 1,130.290 | 4 | Orbitrap | Human Serum | 8 |
| TG000776 | 57.795 | 57.702 | 115.559 | 1,506.718 | 3 | Orbitrap | Human Serum | 12 |
| TG002926 | 59.150 | 58.708 | 112.155 | 1,130.290 | 4 | Orbitrap | Human Serum | 6 |
| TG000944 | 57.888 | 58.021 | 115.170 | 1,506.718 | 3 | Orbitrap | Human Serum | 11 |
| TG005211 | 75.001 | 75.059 | 110.538 | 1,130.290 | 4 | Orbitrap | Human Serum | 11 |
| TG001264 | 59.340 | 59.407 | 104.195 | 1,506.718 | 3 | Orbitrap | Human Serum | 12 |
| TG002995 | 59.033 | 59.041 | 110.438 | 1,130.290 | 4 | Orbitrap | Human Serum | 12 |
| TG001180 | 57.544 | 57.651 | 115.350 | 1,506.718 | 3 | Orbitrap | Human Serum | 11 |
| TG000929 | 57.888 | 58.035 | 115.206 | 1,130.290 | 4 | Orbitrap | Human Serum | 11 |
| TG000097 | 57.659 | 57.631 | 115.206 | 1,130.290 | 4 | Orbitrap | Human Serum | 9 |
| TG002964 | 59.123 | 58.972 | 109.917 | 1,130.290 | 4 | Orbitrap | Human Serum | 11 |
| TG002992 | 59.185 | 59.027 | 113.293 | 1,130.290 | 4 | Orbitrap | Human Serum | 9 |
| TG001124 | 57.544 | 57.515 | 115.005 | 1,130.290 | 4 | Orbitrap | Human Serum | 9 |
| TG000893 | 58.378 | 58.270 | 116.116 | 1,506.718 | 3 | Orbitrap | Human Serum | 10 |
| TG000895 | 58.378 | 58.175 | 115.877 | 1,130.290 | 4 | Orbitrap | Human Serum | 9 |
| TG001263 | 59.340 | 59.059 | 103.227 | 1,130.290 | 4 | Orbitrap | Human Serum | 10 |
| TG005013 | 61.025 | 61.025 | 105.407 | 1,130.290 | 4 | Orbitrap | Human Serum | 11 |
DIA Transition Groups
| Exp. R.T. | Peak R.T. | Norm. R.T. | Prec. m/z | Prec. z | Inst. | Sample | Intensity | |
|---|---|---|---|---|---|---|---|---|
| TG003965 | 60.574 | 60.574 | 119.605 | 1,506.718 | 3 | Orbitrap | Human Serum | 2,848,850 |
| TG003966 | 60.564 | 60.564 | 119.581 | 1,130.290 | 4 | Orbitrap | Human Serum | 1,406,170 |
| TG008199 | 44.840 | 44.840 | 118.999 | 1,130.290 | 4 | TripleTOF | Human Serum | 420,784 |
| TG009113 | 44.669 | 44.669 | 123.906 | 1,130.290 | 4 | TripleTOF | Human Serum | 392,370 |
| TG009416 | 45.633 | 45.633 | 125.564 | 1,130.290 | 4 | TripleTOF | Human Serum | 302,575 |
| TG008801 | 45.404 | 45.404 | 125.157 | 1,130.290 | 4 | TripleTOF | Human Serum | 290,342 |
| TG010639 | 45.299 | 45.299 | 123.954 | 1,130.290 | 4 | TripleTOF | Human Serum | 83,911.5 |
| TG010234 | 44.724 | 44.724 | 121.654 | 1,130.290 | 4 | TripleTOF | Human Serum | 72,287.9 |
| TG009789 | 44.541 | 44.541 | 122.979 | 1,130.290 | 4 | TripleTOF | Human Serum | 42,434.2 |
| TG007093 | 45.031 | 45.031 | 122.329 | 1,130.290 | 4 | TripleTOF | Human Serum | 37,832.5 |
| TG007349 | 44.875 | 44.875 | 121.366 | 1,130.290 | 4 | TripleTOF | Human Serum | 34,411.9 |
| TG007904 | 44.743 | 44.743 | 120.941 | 1,130.290 | 4 | TripleTOF | Human Serum | 32,794.4 |
| TG006869 | 44.875 | 44.875 | 121.076 | 1,130.290 | 4 | TripleTOF | Human Serum | 31,809.2 |
| TG005595 | 41.524 | 41.524 | 110.737 | 1,130.290 | 4 | TripleTOF | Human Serum | 624.07 |
| TG004425 | 41.832 | 41.832 | 123.629 | 1,130.290 | 4 | TripleTOF | Human Serum | 370.247 |